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Plant cell culture strategies for the production of natural 
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Marisol Ochoa-Villarreal1, Susan Howat1, SunMi Hong2, Mi Ok Jang2, Young-Woo Jin2, Eun-Kyong Lee 2 & Gary J. Loake1,*
1Institute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, UK, 2Unhwa Corp., 
Jeonju 55017, Korea
Plants have evolved a vast chemical cornucopia to support 
their sessile lifestyles. Man has exploited this natural resource 
since Neolithic times and currently plant-derived chemicals 
are exploited for a myriad of applications. However, plant 
sources of most high-value natural products (NPs) are not do-
mesticated and therefore their production cannot be under-
taken on an agricultural scale. Further, these plant species are 
often slow growing, their populations limiting, the concen-
tration of the target molecule highly variable and routinely 
present at extremely low concentrations. Plant cell and organ 
culture constitutes a sustainable, controllable and environ-
mentally friendly tool for the industrial production of plant 
NPs. Further, advances in cell line selection, biotransforma-
tion, product secretion, cell permeabilisation, extraction and 
scale-up, among others, are driving increases in plant NP 
yields. However, there remain significant obstacles to the com-
mercial synthesis of high-value chemicals from these sources. 
The relatively recent isolation, culturing and characterisation 
of cambial meristematic cells (CMCs), provides an emerging 
platform to circumvent many of these potential difficulties. 
[BMB Reports 2016; 49(3): 149-158]
INTRODUCTION
Plants have evolved a vast chemical cornucopia driven primar-
ily by the requirement to protect themselves from microbial 
pathogens, insect pests and grazing animals. To date approx-
imately 200,000 NPs have been identified (1) and some of 
these have been utilised as drugs (codeine, morphine, paclitax-
el) (2), food flavouring and colouring agents (saffron, spearmint 
and anthocyanins) (3, 4), pest and disease management chem-
icals (nicotine, strychnine and azadirachtin) (5, 6) and cos-
metics and fragrance products (lavender, rosemary and Aloe 
vera) (7, 8). However, only a tiny fraction of this vast chemical 
space has been mined to date, therefore many blockbuster 
molecules await exploitation. 
A variety of different methods have been developed to pro-
duce NPs, depending on molecular complexity, relative de-
mand and the economics of production. A common strategy 
for obtaining NPs is extraction from the source plant but typi-
cally these plants have not been domesticated and their 
wild-populations maybe limiting. Additionally, the slow 
growth rate of the given source plant frequently reduces pro-
duction potential. The typically low concentration of the active 
molecule in the source plant is also a potential brake on 
production. 
The total chemical synthesis of NPs is an important alter-
native strategy. For molecules of relatively simple structure this 
provides an attractive route for production. Many NPs, how-
ever, have multiple chiral centres with region-specific and ster-
eo-specific properties associated to their function (9), making 
total chemical synthesis either difficult or unprofitable. The 
production of NPs via semi-synthesis represents another ap-
proach that can circumvent some of the issues associated with 
the total synthesis of these high-value plant chemicals. This 
strategy is based on harvesting a more abundant chemical pre-
cursor integral to the biosynthetic pathway responsible for the 
generation of the target NP. For example, the production of the 
diterpenoid, paclitaxel (10). Semi-synthesis routes, however, 
still typically remain costly and often also generate toxic 
by-products, which can be damaging to the environment (9). 
Plant cell culture (PCC) is a well-established technology plat-
form for the synthesis of NPs. This approach provides several 
advantages in comparison to other potential strategies, espe-
cially for the production of NPs with complex structures. 
Significant progress has been made recently in plant cells plat-
forms, building on the established expertise in microbial and 
animal cell culture. This has enabled the successful scale-up 
from experimental platforms to commercially feasible in-
dustrial scale processes. Thus, facilitating a series of high-value 
NPs to become commercially competitive in the market place, 
especially those of high-value (11). 
The development of powerful new “omics” technologies, in-
cluding next generation sequencing has provided exciting op-
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Industry Products Species Manufacturer Use/Notes
Plant Natural Products
Food Anthocyanins Euphorbio milii
Aralia cordata
Nippon Paint Co. Ltd, 
Osaka Japan
Textile dye
Coloring agents 
Arbtin Catharanthus roseus Mitsui Chemicals Inc., 
Tokio Japan
Pigments
Betacyanin Beta vulgaris Nippon Shinyaku Co., Ltd Pigments
Carthamin Carthamus trinctorius Kibun Foods Inc., 
Tokio Japan
Pigments
Geraniol Geraminea spp. Mitsui chemicals., Inc Essential Oils
Gingseng Panax gingseng Nitto Denko Corporation, 
Osaka, Japan
Dietary supplements
Wild gingseng 
from CMCs
Unhwa Biotech Corp., 
Jeonbuk, South Korea
Dietary supplements, cosmetic and 
medical products
Shikonin Lithospemum 
erythrorhizon
Mitsui Chemicals., Inc Red pigments
Pharmaceuticals Berberines Coptis japonica
Thalictrum minus
Mitsui Chemicals, Inc Anticancer
Antibiotic Anti-inflammatory
Echinacea 
polysaccharides
Echinacea purpurea
Echinacea angustifolia
Diversa, Ahrensburg, 
Germany
Immunostimulant
Anti-inflammatory
Paclitaxel Taxus spp Phyton Biotech., Inc
Germany
Anticancer World's largest cGMP 
plant cell culture facility with 
bioreactors specifically designed to 
meet the needs of plant cell culture
Samyang Genex., 
Seoul, South Korea
Anticancer
Podophyllotoxin Podophyllum spp. Nippon Oil, Tokio, Japan Anticancer
Rosamarinic acid Coleus blumei ANattermann & Cie. 
Gmbh, Cologne, 
Germany
Anti-inflammatory
Scopolamine Duboisia spp. Sumitomo Chemical Co., 
Ltd, Tokio, Japan 
Anticholinergicum
Antimuscrnic
Used in treatment of motion sickness, 
nausea and intestinal cramping
Cosmetic Atropine, Gingsenosides,
Coumarines, Flavonoids,
Alkaloids, Camptothechin,
Anabasine, Nicotine
Hairy roots from 
Atropa belladonna
Carlina acaulis
Nicotiana glauca
Panax gingsen
Rootec, Witterswil, 
Switzerland
A wide range of products 
for beauty health and nutrition
About fifteen active 
ingredients for 
cosmetic use
Cell suspension cultures 
and hairy roots cultures,
different species
Sederma, 
Le Perray-en-Yvelines, 
France
Develop of cosmetic active ingredients
Active ingredients for 
cosmetic use
Suspension culture 
and hairy roots 
Malus domestica
Solar vitis
Mibelle, Switzerland Develop of cosmetic active ingredients
Table 1. Commercial production of natural products and heterologous proteins in plant suspension and hairy root culture. Modified from (15)
portunities for PCC. In this context, the number of patents re-
lated to PCC products has risen to a total of 28,000 and the 
amount of companies utilising PCC or hairy root technologies 
for the production of NPs associated with the cosmetic, food 
and pharmaceutical industries continues to rapidly expand 
(Table 1). Here we provide an update on the generation of NPs 
utilising PCC and highlight some of the strategies that can be 
undertaken to increase NP yields including: cell line selection, 
permeabilisation, biotransformation, scale-up strategies, im-
mobilization, product secretion; and, the opportunities pre-
sented by the relatively recent isolation and culture of cambial 
meristematic cells (CMCs). 
PLANT CELL CULTURES
PCC has become a well establish platform to produce plant 
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Industry Products Species Manufacturer Use/Notes
Heterologous proteins
Human Glucocerebrosidase 
(GCD) enzyme
Carrot suspension 
cultures
Protalix BioTherapeutics 
Karmiel, Israel
ELELYSOⓇ Plant cell-expressed form 
of the glucocerebrosidase enzyme 
for treatment of Gaucher disease
Vaccine against Newcastle 
disease virus (NDV)
Tobacco suspension 
cultures
Dow Agrosciences, LLC, 
Indianapolis, USA
First tobacco cell-based vaccine 
approved by the FDA against 
Newcastle disease virus in poultry
Human proteins Physcomitrella patens 
suspension cultures
Greenovation Biotech 
BMBH Freiburg, 
Germany 
-galactosidase for Fabry disease 
and -glucocerebrosidase 
for Gaucher disease.
Both are in phase 1 of clinical trials 
Glycosylated recombinant 
proteins
Hairy roots Root Lines
Amiens, France
Rhizo prot platform
Table 1. Continued
NPs for the food, cosmetic and drug industries. In addition, 
this platform provides important tools to drive basic research. 
The production of valuable NPs using PCC has begun to gar-
ner significant attention due to its advantages relative to the 
production of NPs from natural harvest or semi-synthesis, from 
more abundant natural precursors (12). PCC provides a power-
ful production system for NPs independent from constraints re-
sulting form geographical and seasonal variation and also limi-
tations resulting from access to often dwindling wild plant 
populations. Thus, the PCC platform can aid the establishment 
of robust supply chains and help alleviate ecological problems 
and the loss of plant biodiversity (13-15). Importantly, the pro-
duction of NPs from PCC is independent of food production. 
Further, the application of PCC technology reduces the re-
quirement for precious water resources associated with con-
temporary agricultural production regimes. Commercializa-
tion of NPs produced via PCC have also gained significant 
consumer acceptance, since they are categorized as non-GMO 
(16, 11).
Plant cell suspension cultures offer the most reliable and 
productive system to generate NPs. An example of this is the 
production of geraniol, an important monoterpenoid for fla-
vour and fragrance industries (17). While this NP was synthe-
sized to slightly higher levels in transgenic tobacco plants, 
PCC proved to be overall the more commercially viable sys-
tem when the simplicity in handling and the continuous nature 
of the process were taken into consideration. Thus, PCC was 
established as the ideal plant-based expression platform for the 
production of geraniol and related NPs (18). Furthermore, by 
utilising an appropriate culture medium and optimal levels of 
phytohormones, it is possible to establish in vitro cultures of 
most plant species. Following successful callus formation, cell 
suspension cultures can subsequently be generated, simply by 
adding these cells to a liquid medium. The resulting cultures 
typically have significant scale-up capability for their growth 
within industrially relevant bioreactors designed to maximize 
levels of NP biosynthesis.
HAIRY ROOT CULTURES
The cultivation of differentiated cells in organized tissues such 
as roots or shoots, constitutes an important alternative strategy 
for the production of high-value NPs (19). Hairy root culture 
are generated following infection with the gram-negative, soil 
bacterium Agrobacterium rhizogenes, which transfers a Trans-
fer (T)-DNA from its large root-inducing (Ri) plasmid into the 
genome of the infected plant (20). The T-DNA carries a set of 
genes that encode for enzymes responsible for modulating 
auxin and cytokinin accumulation. The new hormone balance 
at the infection site mitotically activates surrounding cells in-
ducing the formation of proliferating roots, so-called hairy 
roots. This phenotype is characterized by extensive branching, 
lack of geotropism and a high grow rate in the absence of 
exogenous hormones, (20, 21). Hairy root cultures are rela-
tively easy to maintain and are genetically stable. Hairy root 
cultures have a successful track record in the production of a 
wide range of NPs including nicotine, ginsenosides, campto-
checin, tropane and pyrrolizidine alkaloids (19, 20, 22). 
However, an important limitation in the production of NPs 
from hairy roots is that the target molecule must be synthe-
sized within the roots of the given source plant. This is sig-
nificant because relatively few NPs are synthetized in root tis-
sues, with the majority produced in aerial structures. Further, 
another potential issue is that some root synthesized NPs are 
often translocated away from their site of production via either 
the phloem or xylem to distant sink tissues, where they are 
stored for chemical defence (22). Nevertheless, a number of 
NPs are both synthesized and accumulated in roots, including: 
scopolamine, atropine, anthraquinone, indole alkaloids car-
diac glycosides (23). 
Another major limitation for the industrial-scale production 
of NPs using hairy roots is the development of appropriate bio-
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reactor production platforms. Recent developments in bio-
process engineering have, nonetheless, driven the construction 
of bioreactors compatible with the industrial scale-up of hairy 
root systems. For example, ROOTec has developed a mist- 
based bioreactor for the production of a number of high-value 
NPs from a variety of plant species (http://www.rootec.com/) 
Table 1. In addition to NPs, hairy root cultures have gained at-
tention for the production of pharmaceutical proteins due to 
their simple growth media requirements, genetic stability and 
capacity for scale-up (20). Thus, Root Lines Technology Inc. 
(http://www.rootlines-tech.com/) (Table 1) have exploited these 
properties for the industrial-scale production of recombinant 
glycosylated proteins. 
CELL LINE SELECTION FOR ENHANCED NP 
PRODUCTION 
Due to the heterogeneous population of typical dediffer-
entiated cells (DCCs) that comprise callus, the selection of a 
highly productive cell line has been an essential step for the 
establishment of profitable production platforms for NPs. As 
the accumulation of NPs in plants is genotype specific, the se-
lection of suitable species and subsequently organs for callus 
generation is crucial (24). In addition, this selection process 
can be facilitated by elegant chemical-based approaches. For 
example, the identification of cell lines exhibiting a high level 
of metabolic flux through the targeted pathway by the exoge-
nous application of an intermediate. Thus, cell lines with en-
hanced biosynthesis of rosmarinic acid in Lavandula vera were 
obtained by adding two different analogues of phenylalanine 
(m- and p-F-D,L phenylalanine), the substrate of phenylalanine 
ammonia-lyase (PAL), to the medium. Only cell lines with 
high levels of PAL activity were resistant to the analogue, re-
flecting their ability to produce elevated levels of the target 
NP, rosmarinic acid (25). In a similar fashion, high producing 
shoots of Mentha arvenis were screened by the addition of 
menthol into the medium. The selected clones exhibiting high 
menthol tolerance identified genotypes with superior perform-
ance for the production of increased quantities of menthol, for 
possible large scale production (26).
A major limitation following the selection of a suitable cell 
line for NP production is that cell lines often loose their ability 
to produce the desired NP (15, 19, 27). This decrease or com-
plete loss of NP biosynthesis is thought to be due to genetic in-
stability resulting from somaclonal variation. This chromoso-
mal rearrangement that occurs during long-term subculture, 
has been associated with aneuploidy and polyploidy. The re-
sulting genetic variation affects chromosome structure causing 
genetic modifications including deletions and insertions that 
may affect the production of NPs (28). Subpopulations of cells 
with different DNA contents due to a change in ploidy were 
found in Taxus media cells after 1 year of subculture (29). 
Further, differences in ploidy are related to changes in gene 
expression, in general higher ploidy appears to result in the si-
lencing of an increased number of genes (28). Changes in cul-
ture performance resulting from these deleterious genetic 
changes typically necessitates periodic screening in order to 
maintain the desirable characteristics of the given culture sys-
tem (29). In this context, the application of a selectable marker 
within plant cells under culture, combined with flow sorting 
techniques, has been utilised to circumvent this problem, 
maintaining high performing cells for more than 12 months 
(30).
CULTURE CONDITION OPTIMIZATION 
Following selection of high performing cell lines, another key 
consideration is to establish optimum media and culture 
composition. Optimization of growth, maintenance and pro-
duction media are necessary to achieve high NP production. 
Although standard PCC medium such as MS (31), SH (32), 
Gamborg B5 (33) and LS (34) provide a platform for the 
growth and maintenance of plant cell lines, enhanced pro-
duction of NPs can be manipulated by further media modi-
fication. Significant benefits can be gained by identifying the 
optimum culture medium environments early in the pro-
duction timeline, addressing the integrity and stability of the 
specific NP to be produced. Some of the most useful mod-
ification made in the growth medium to promote NP pro-
duction are related to the source of energy, nitrogen, phos-
phate, growth regulators, and inoculum density (24). 
In general plant cell growth and the production of NPs are 
inversely related. Thus, production of NPs typically occurs in 
late stationary phase and is associated with growth inhibition 
and the production of enzymes for secondary metabolism. 
Therefore, a dual system to produce NPs is particularly effec-
tive, in which the first phase is for cell growth, followed by 
cell transfer to production medium, which does not support 
growth, but is favorable for NP biosynthesis (35). Typical mod-
ifications to the production medium include the reduction or 
elimination of phytohormones such as 2,4-D; reduction in 
phosphate levels; an increase in sucrose levels or modification 
of the carbohydrate:nitrogen ratio (35). 
Screening of high producing genotypes, selection of ad-
equate medium, and optimization of the culture environment 
for PCC may increase production of NPs by 20-30-fold (19). 
However, the optimization of plant-based production systems 
is a relatively nascent area. In this context, promising new 
strategies are emerging that hold significant promise for future 
application. For example, the use of a non-invasive, in-line sys-
tem to monitor cell biomass during culture can be an im-
portant step to maximize product yield and quality, while im-
proving culture nutrients (36). Also, culture parameters includ-
ing levels of phytohormones and components within the me-
dia can be optimized more rapidly by employing a statistical 
design of experiments approach (37). This strategy has been 
shown to be successful for the optimization of culture parame-
ters for M12 antibody production in hairy root cultures 
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(Häkkinen et al., 2014) and in the production of a human anti-
body in a BY-2 tobacco cell suspension culture (37). The same 
strategy has also been used to promote biomass accumulation 
and geraniol production in tobacco cell suspension cultures 
(39). Therefore, experimental design strategies, in combination 
with in-line monitoring, maybe greatly beneficial during the 
early steps in screening and optimization for the establishment 
of high producing cell lines. 
ELICITATION
The biosynthesis of NPs is integral to plant immune responses 
activated in response to attempted pathogens ingress or ex-
posure to a range of abiotic stresses (40). Therefore, so-called 
elicitors, derived from pathogen associated, plant immune-re-
lated or stress signalling molecules, can trigger immune or 
stress-related NP production. A diverse range of biotic elicitors 
have been utilized including plant cell wall fragments (pectin 
and cellulose) and polysaccharides from microorganism (chitin 
and glucan) (41, 42), plant immune signalling molecules 
(salicylic acid and methyl-jasmonate (MeJA) (43, 44). Abiotic 
elicitors include: inorganic salts, heavy metals, UV irradiation, 
high salinity and high pressure (45). The application of the im-
mune-related MeJA has been particularly widely utilized. For 
example, addition of MeJA to Taxus cuspidata CMCs induced 
the production of the blockbuster anticancer drug, paclitaxel, 
14,000% in comparison with mock-treated cells (46). 
Elicitor concentration, cell age and the stage of the given 
culture at the moment of elicitation are all important factors 
necessary to optimize the production of NPs (24). Thus, a sig-
nificantly higher production of paclitaxel was obtained when 
MeJA was added to an 8 day-old culture in comparison to a 14 
day-old culture (44). The addition of a combination of elicitors 
is another common practice in PCC with the advantage not on-
ly in increasing the production of a given NP but also often its 
release into the medium. The employment of MeJA in combi-
nation with cyclodextrin led to a synergistic effect on resvera-
trol production in grapevine cell cultures (47). A synergistic ef-
fect was also found on paclitaxel accumulation in T. media 
cells using MeJA and cyclodextrins. Both elicitors induced tax-
anes and advantageously, paclitaxel was detected mainly in 
the culture medium. Interestingly, this correlated with elevated 
expression levels of genes encoding ABC transporters. There-
fore, if this process could be successfully scaled-up, purifica-
tion costs for paclitaxel could be significantly reduced (48). 
IMMOBILIZATION OF PLANT CELLS
Immobilization techniques were initially developed to immo-
bilize enzymes for applications in the industrial production of 
sugars, amino acids and pharmaceutical products (49). Subse-
quently, immobilization was utilized to enclose cells. The ad-
vantages of this technique are that it provides high cell con-
centrations for use in small bioreactors, protection from shear 
stress for cell lines with high sensitivity and increases product 
formation by enabling maintenance of biomass over a pro-
longed period (24). Given that most NPs are produced in the 
stationary phase of growing cells, immobilization potentially 
could create an excellent environment for the production and 
accumulation of plant NPs. The most common immobilization 
agent is calcium alginate which has been deployed in the pro-
duction of paclitaxel (50), vanillin, ajmalicine and capsaicin 
(51). However, there are no currently registered companies 
that utilize plant cell immobilization as a platform to produce 
NPs. Immobilization has been employed for the commercial 
production of pharmaceutical proteins where cell encapsula-
tion in alginate increased the production of human gran-
ulocyte-macrophage colony-stimulating factor (GM-CSF) in to-
bacco cells by ∼50% (52). Thus, the application of immobi-
lized plant cells may constitute a significant opportunity to en-
hance the future industrial production of NPs. Nevertheless, 
limitations associated with nutrient and metabolite mass trans-
fer remain a challenge to be addressed before the imple-
mentation of immobilized plant cells at commercial level for 
NP production can commence.
PERMEABILISATION, SECRETION AND EXTRACTION 
OF NPs
Permeabilisation aids the release of given products without af-
fecting cell viability and the biosynthesis capacity of cell 
cultures. Cell permeabilisation facilitates the removal of NPs 
from vacuoles and membrane systems of the plant cell facilitat-
ing the secretion of products into the culture medium, sim-
plifying purification procedures (51). Different permeabilising 
agents have been used to facilitate the release of the product 
stored, including the organic solvents isopropanol and dime-
thylsulfoxide (DMSO) and also chitosan (53). The concen-
tration and time of addition of the permeabilising agent to the 
medium are key parameters to avoid cell growth inhibition. In 
the case of Taxus chinensis cell cultures the addition of a low 
concentration of hexadecane, decanol and dibutylphthalate 
contributed to the release of paclitaxel into the medium (54).
The accumulation of NPs can be affected by enzymatic or 
non-enzymatic degradation of the NP in the medium (51) 
and/or by feedback inhibition of product synthesis (54). The 
application of in situ product removal, aims to prevent any 
subsequent cross interference between the product and the 
producing cell (55). In situ product removal involves direct 
separation of the product from the culture medium while its 
production is progressing and may be undertaken either by liq-
uid-solid (in situ adsorption) or liquid-liquid (in situ extraction) 
systems (56). These processes can aid product recovery, in-
creasing culture productivity and mitigating toxicity caused by 
waste materials released from cells, significantly decreasing 
the cost of downstream processing. Solid-liquid systems such 
as activated charcoal, XAD-4 and XAD-7 resins typically en-
able better outcomes compared with liquid-liquid systems. 
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Activated charcoal has been used to increase the production of 
vanilla and coniferyl aldehyde. XAD-4 has been successful em-
ployed for chlorogenic acid, caffeine, paclitaxel and vanilla. 
While XAD-7, has improved the production of anthraquinon-
ces, ajmalicine, serpentine, plumbagin and paclitaxel (56).
BIOTRANSFORMATION
Biotransformation is another strategy that can be used to pro-
duce high-value-chemical products in plant cells or organ tis-
sues (24, 57). Biotransformation involves the chemical con-
version of supplied substances catalyzed by biological sys-
tems, plant cells organ tissues or enzymes (58, 59). This strat-
egy has the advantage of transforming inexpensive, available 
and plentiful products into rare, expensive and high-value 
NPs. The method is based on exploiting enzyme reactions in-
cluding: hydroxylations, glycosylations, oxidoreduction, hy-
drogenation, hydrolysis, methylations, acetylation, isomer-
izations and esterifications (59, 60).
Previously, the application of biotransformation was limited 
by the absence of knowledge related to plant secondary me-
tabolism (59). However, the recent advances in “omics” tech-
nologies have enabled significant advances in our under-
standing of plant secondary metabolism. Hairy root cultures, 
due to their genetic and biochemical stability, plant hormone 
independence and inexpensive culture requirements, offer a 
particularly attractive platform for the application of bio-
transformation (58). In this context, biotransformation of cin-
namyl alcohol to rosavins in hairy roots of Rhodiola kirilowii 
produced 80-95% of the glycosides released to the culture me-
dia (61). Importantly, biotransformation can drive the discov-
ery of novel plant NPs. For example, a novel terpenoid indole 
alkaloid in suspension cultures of C. roseus was identified by 
biotransformation of catharantine. The new metabolite was 
identified as 3-hydroxy-4-imino-catharanthine (62). Therefore, 
biotransformation constitutes an important alternative to the 
semi-synthesis strategy by enabling improved stereospecific 
characteristics, bioavailabilty and the potential to lower the 
toxicity of the desired NPs.
CAMBIAL MERISTEMATIC CELLS 
An exciting recent technological development in PCC is the 
isolation, culture and application of CMCs for high-value NP 
production (46). CMCs are isolated from procambium mer-
istematic cells, which are responsible for the production of xy-
lem and phloem within the vasculature (63). CMCs are un-
differentiated cells that grow indefinitely and function as plant 
stem cells (12, 46). Isolation of CMCs from T. cuspidata, Ging-
seng panax and Solanum lycopersicum has been reported (46). 
Recently, the isolation of CMCs from Catharanthus roseus for 
the production of vindoline, catharanthine and ajmalicine has 
also been described (64, 65).
An important factor that negatively impacts cell culture per-
formance is the heterogeneous nature of cultured cells. Typi-
cally, contemporary cell cultures are comprised of dediffer-
entiated cells (DDCs). These cells consist of a mixture of differ-
ent cell types resulting in a high level of heterogeneity, which 
significantly contributes to the variability routinely associated 
with suspension cultures (66). As CMCs are innately undif-
ferentiated plant stem cells, CMCs bypass the negative effects 
associated with the differentiation step, offering stability in 
product accumulation for longer periods (46).
Biomass production is another important factor required to 
achieve high levels of NP synthesis. T. cuspidata CMCs 
showed superior growth compared to needle or embryo-de-
rived T. cuspidata DDCs when using a solid growth media for-
mat over 22 months of culture. Further, when CMCs were 
placed on liquid media they exhibited reduced aggregation. 
This is significant, because cell cluster formation can inhibit 
oxygen and nutrient distribution decreasing NP yield (46). 
The reduced aggregation size of CMCs (2-3 cell clusters) al-
so decreases shear sensitivity. Shear stress is a crucial limi-
tation in the scale-up of plant cells, affecting cells by causing 
ether lysis or death due to fluid motion (67). When cultured in 
a 10 L stirred tank bioreactor T. cuspidata CMCs grew consid-
erably faster in comparison with DDCs, which rapidly turned 
necrotic (46). In addition, to aggregation size, the abundant va-
cuoles and thin cell wall characteristic of CMCs are also 
thought to increase tolerance to shear stress.
CMCs are also highly responsive to elicitation. For example, 
the addition of MeJA, a plant immune activator, increased the 
production of paclitaxel in T. cuspidata CMCs by 14,000% rel-
ative to the production of paclitaxel in needles or embryo-de-
rived DDCs of 220% and 430%, respectively (46). In C. roseus 
CMCs, the addition of MeJA, -cyclodextrin (-CD) or a com-
bination of both elicitors, increased the production of ajmali-
cine by 15, 32 and 108% respectively, relative to non-treated 
cells (64). Unfortunately, in this case, no direct comparison 
was made to elicitation in DDCs.
Direct secretion of produced NPs into the media facilitates 
simpler and less expensive downstream processing, especially 
important for the industrial scale production of NPs. The ca-
pacity of CMCs to release the target NP into the media was as-
sessed during airlift perfusion culture in a 3L bioreactor. This 
style of bioreactor is frequently used for NP production as it 
can improve both the purification and biosynthesis of the giv-
en NP (54). After 45 days of perfusion culture 74% of paclitax-
el from T. cuspidata CMCs was release into the medium pro-
ducing a total of 264 mg/kg of paclitaxel (46). In contrast, T. 
cuspidata DDCs cultured in an identical system were largely 
necrotic. Perfusion culture of CMCs therefore both promotes 
paclitaxel biosynthesis and increases the proportion of this NP 
that is secreted into the medium.
The use of CMCs provides a promising platform for the pro-
duction of NPs especially complex molecules synthesized via 
complicated and poorly characterized biochemical pathways. 
We anticipate that the application of CMCs to produce NPs 
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will rapidly increase in future years due to the established 
manifold advantages of these cells over that of DDCs. The util-
ity of CMCs for industrial scale production has already been 
established with the production of gingsenosides from P. ging-
seng CMCs for the production of nutritional, cosmetic and 
medical products (Table 1) (12). Further, numerous other prod-
ucts derived from CMCs of various plant species are now in 
development. 
SCALE-UP STRATEGIES FOR NP PRODUCTION
Scaling-up plant cell and organ cultures from lab to industrial 
scale is obviously a critical step that is often rate limiting for 
commercialization of NP production. The scaling-up from 
shake flasks to bioreactors is typically not straightforward due 
to changes in the cell growth environment in terms of hydro-
dynamic shear forces and rheological properties (68). 
Fortunately, some of these limitations can be overcome with 
improved bioreactor design and optimizing key parameters of 
the culture and system such as low-shear environment, re-
ducing mass transfer for improved oxygen and nutrient avail-
ability and adequate mixing (68, 69). 
Large-scale culturing of plant cells has been conducted in a 
variety of bioreactors including standard stirred-tank bio-
reactors (STR), bubble column bioreactors (BCB), air-life bio-
reactors (ALB) and other more recent bioreactor designs in-
cluding: wave bioreactors, membrane bioreactors, hollow fi-
ber bioreactors and rotating drum reactors (27, 69, 70). The 
most widely exploited bioreactor is STR, which provides rela-
tively easy scale-up, good fluid mixing and oxygen transfer 
ability and relatively easy compliance with current Good 
Manufacture Practices (cGMP). However, BDB and ALB bio-
reactors are less expensive, in some cases can provide an eas-
ier route to scale-up and are generally more straightforward to 
construct. 
Bioreactors are distinct in their modes of operation with 
batch culture systems typically used in large-scale PCC. How-
ever, standard batch processes are often not cost-effective as re-
peated sterilization, filling and cleaning of the system are 
required. These factors drove the development of more ad-
vanced culture systems such as: fed-back, two-stage, perfusion, 
semi-continuous and continuous cultures. The choice of the 
type of culture largely depends on the nature and character-
istics of the NP to be synthesized and the specific growth rate, 
aggregation properties and stress sensitivity, among others, of 
the plant cells or organ culture to be cultured (69). Perfusion 
culture, in which fresh medium is continually fed and waste 
cell-free medium is constantly removed, often provides an opti-
mal approach. The removal of spent media favors productivity 
and helps eliminate the possibility of inhibition caused by the 
accumulation of inhibitory metabolites in the medium. However, 
perfusion bioreactors typically run on a smaller scale in com-
parison with batch cultures. Although, because plant cells can 
be reused, this maximises the turnaround time between batch-
es significantly increasing productivity (69, 71).
An intriguing relatively recent innovation is the use of dis-
posable bioreactors, which can provide platforms for small 
and medium scale NP production. The disposable bioreactors 
are made of FDA-approved biocompatible synthetic polymers 
including: polyethylene, polystyrene, polytetrafluorethylene, 
polypropylene, and ethylene acetate. These can be, pre-steri-
lized and then discarded after harvest, minimizing the cost of 
clean-up and re-sterilization steps associated with mitigating 
contamination risks (69, 72). Various types of disposable bio-
reactors are currently in use for PCC including: wave-mixed, 
slug bubble, plastic-lined, stirred bag orbital shaken or stirred 
bioreactors. Wave bioreactors perhaps represent the most suc-
cessful type of disposable bioreactor. These consist of an in-
flated bag placed on a rocking platform that induces wave ac-
tion within the liquid medium. This disposable bioreactor sys-
tem has been employed for a number of different plant cell 
species including: Vitis vinifera, Malus domestica, Nicotiana 
tabacum (BY-2) and hairy root cultures: Harpagophytum pro-
cumbens, Hyoscyamus muticus and P. ginseng (73). Further-
more, wave-mixed bioreactors operating in batch and feed 
mode are already established for the production of NPs for 
cosmetic products (69).
CONCLUSIONS
Plants have evolved the capacity to synthesise a vast array of 
complex chemicals. These natural products have long found a 
plethora of applications as medicines, dyes, fragrances and 
flavours. Interest in natural products is now ramping up again, 
however, due in part to many regulatory agencies increasingly 
not permitting the addition of synthetic colourants or flavours 
in food, following studies indicating the possible toxicity of 
some of these molecules (74). There has also been a recent 
shift in consumer demand for natural molecules. This has been 
driven in part by the growing appreciation of the potential 
health benefits associated with the consumption of NPs. Also, 
within the pharmaceutical industry, drug screens using NP col-
lections are increasingly being deployed, as libraries of mole-
cules synthesized by combinatorial chemistry beginning to fall 
out of favour. Collectively, an increasing interest in developing 
improved strategies for the production of NPs has therefore 
evolved. 
Chief among the platform technologies for NP biosynthesis 
is PCC. However, the utility of classic DDCs has significant 
limitations including: a relatively slow growth rate, instability 
of product yield, sensitivity to shear stress and generation of 
low concentrations of the given NP. Further, biosynthesis of 
the target chemical might be localised to other organs rather 
than roots, precluding the employment of hairy root cultures. 
Nevertheless, recent developments in cell the selection of high 
performing cell lines, biotransformation, cell permeabilisation 
and culture optimisation, among others is beginning to in-
crease the utility of DCCs and hairy root cultures (Fig. 1). 
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Fig. 1. Strategies for the production of natural products from ei-
ther plant cell suspensions or hairy root culture for the pharma-
ceutical, cosmetic or food industries.
When applied in combination these advances are particularly 
powerful. For example, in situ product removal, in tandem 
with elicitation and immobilization increased the production 
of ajmalicine in C. roseus cell suspension from 2 mg/L to 90 
mg/L (75). Superimposed upon these is the recent isolation, 
culture and deployment of CMCs. These innately undifferen-
tiated cells, plant stem cells, circumvent many of the current 
limitations associated with the application of DDCs and hairy 
root cultures. Thus, the use of CMCs with rather than DDCs, in 
combination with the new advances in associated PCC tech-
nologies, such as biotransformation or cell permeabilisation, 
will provide significant opportunities for the production of NPs 
in plants. Especially, when aligned with the recent develop-
ments in scale-up capability and bioreactor design. Therefore, 
there are exciting times ahead for both academic research and 
commercial development within the area of plant NPs. 
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